SAN DIEGO--(BUSINESS WIRE)--
Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the
company’s presentations at two upcoming investment conferences.
Illumina will webcast its presentation at the Cowen and Company 34th
Annual Health Care Conference in Boston, Massachusetts, on March 5,
2014. The live webcast is scheduled to begin at 8:40 AM ET and will
feature a brief overview of the company by Marc Stapley, Senior Vice
President and Chief Financial Officer, followed by a question and answer
Illumina will also webcast its presentation at the Morgan Stanley
Technology, Media & Telecom Conference in San Francisco, California, on
March 6, 2014. The live webcast is scheduled to begin at 9:20 AM PT and
will feature an overview of the company by Jay Flatley, CEO followed by
a question and answer session.
The webcasts can be accessed in the Investor Relations section of
Illumina's web site under the "Company" tab at www.illumina.com.
is a leading developer, manufacturer, and marketer of life science tools
and integrated systems for the analysis of genetic variation and
function. We provide innovative sequencing and array-based solutions for
genotyping, copy number variation analysis, methylation studies, gene
expression profiling, and low-multiplex analysis of DNA, RNA, and
protein. We also provide tools and services that are fueling advances in
consumer genomics and diagnostics. Our technology and products
accelerate genetic analysis research and its application, paving the way
for molecular medicine and ultimately transforming healthcare.
Source: Illumina, Inc.